Meta Plans Two New Ray-Ban Smart Glasses Models Designed Specifically for Prescription Wearers

Meta Plans Two New Ray-Ban Smart Glasses Models Designed Specifically for Prescription Wearers

Meta is preparing to launch two new Ray-Ban smart glasses models next week that are specifically designed for prescription wearers, according to Bloomberg. While Meta’s existing Ray-Ban smart glasses have supported prescription lenses, this marks the first time the company and partner EssilorLuxottica are introducing models built from the ground up for the prescription eyewear market.

Two New Styles: Rectangular and Rounded

The two upcoming models will come in rectangular and rounded frame styles, giving prescription wearers more options that look and feel like traditional eyeglasses rather than tech gadgets. Importantly, these are not a new generation of Meta’s smart glasses — they represent an expansion of the existing product line into dedicated prescription territory.

The glasses will be sold primarily through traditional prescription eyewear channels, including opticians and eyewear retailers, rather than exclusively through Meta’s own store. This distribution strategy signals Meta’s intent to reach mainstream consumers who may not typically shop for tech products online.

FCC Filings Reveal Even More Models Ahead

Beyond the prescription-focused launch, FCC filings have revealed that Meta and EssilorLuxottica are working on two additional next-generation models codenamed “Scriber” and “Blazer.” These appear to be non-display AI glasses, similar to the current Ray-Ban Meta Gen 2 lineup, based on naming conventions Meta has used previously.

The filings reference Bluetooth and Wi-Fi connectivity, along with a charging case — consistent with existing models that offload heavy computing to a connected smartphone. A “Blazer Large” variant also appears in the filings, suggesting size options for different face shapes.

Privacy Concerns Continue to Mount

The expansion comes as Meta faces growing scrutiny over privacy implications of its smart glasses. Recent revelations about the company using sensitive customer videos for AI training, combined with reported plans to add facial recognition capabilities, have drawn attention from U.S. senators who sent a letter questioning Meta’s plans.

Meta has remained largely silent on both the AI training practices and facial recognition concerns, creating an uneasy backdrop for its aggressive smart glasses expansion. The prescription-focused launch could help normalize the devices by making them feel less like surveillance tech and more like everyday eyewear.

The Bottom Line

Meta’s prescription-first approach represents a strategic shift in how smart glasses reach consumers. By meeting people where they already shop for eyewear and offering frames designed specifically for daily prescription use, Meta is betting that the path to mainstream smart glasses adoption runs through the optician’s office rather than the tech store. Whether the mounting privacy concerns will slow that adoption remains to be seen.